2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow COLD-fX: new trials by email Literature Review of COLD-fX trials Research Report on COLD-fX
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy Adults CVT-E002 (Cold-FX); a natural health product - Upper Respiratory Infection | Phase 3 | Completed | CV Technologies | 500 | 2005-12-01 | 2009-06-08 |
| Use of COLD-fX to Prevent Respiratory Infections in Community Dwelling Seniors COLD-fX natural health product, COLD-fX, Placebo - Respiratory Tract Infection | Phase 3 | Completed | Capital Health, Canada | 780 | 2005-09-01 | 2011-07-07 |
Influenza, Human (2) · Respiratory Tract Infections (2) · Common Cold (1) · Infections (1)
CV Technologies (1) · Capital Health, Canada (1)
Canada (2) · Netherlands (1)
Gerry Predy, MD (2) · Albert Osterhaus Dr. (1) · Andrew Simor MD (1) · Jan McElhaney (1) · Shelly McNeil MD (1)